AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (August 5, 2008). doi:10.1152/ajpendo.90429.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/E1047    most recent
90429.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kayahara, M.
Right arrow Articles by Ray, D. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kayahara, M.
Right arrow Articles by Ray, D. W
Submitted on May 9, 2008
Revised on July 30, 2008
Accepted on July 30, 2008

MNAR functionally interacts with both N- and C-terminal GR domains to modulate transactivation

Midori Kayahara1, Jacqueline Ohanian1, Vasken Ohanian1, Andrew Berry1, Ratna Vadlamudi2, and David W Ray1*

1 University of Manchester
2 University of Texas Health Science Center at San Antonio

* To whom correspondence should be addressed. E-mail: david.w.ray{at}manchester.ac.uk.

Glucocorticoids are potent anti-inflammatory agents, acting through the glucocorticoid receptor (GR) to regulate target gene transcription. However, GR may also exert acute effects, including activation of signaling kinases such as c-Src and Akt, possibly via the scaffold protein, MNAR. MNAR inhibited GR transactivation in A549, but in HEK293 cells there was a ligand concentration dependent biphasic effect. Transactivation driven by low ligand concentrations was inhibited by MNAR expression whereas higher ligand concentrations were potentiating. Further analysis revealed that MNAR inhibited transactivation by the ligand independent AF1, but potentiated the C-terminal AF2 domain. The effect of MNAR was independent of c-Src activity, demonstrated by inhibitors and c-Src knockdown studies. In support of the role of MNAR in modulating GR transactivation, co-immunoprecipitation studies showed interaction between MNAR and GR in the nucleus but not the cytoplasm. Furthermore, MNAR and c-Src were also found to physically interact in the nucleus. Immunofluorescence studies showed MNAR to be predominantly a nuclear protein, with significant co-localization with GR. Deletion studies revealed that MNAR 874-1130 was co-immunoprecipitated with GR, and furthermore this fragment inhibited GR transactivation function when overexpressed. In addition, MNAR 1-400, which contains multiple LxxLL motifs, also inhibited GR transactivation. Taken together, MNAR interacts with GR in the nucleus but not cytoplasm, and regulates GR transactivation in a complex manner depending on cell type. MNAR is capable of regulating both AF1 and AF2 functions of the GR independently. MNAR expression is likely to mediate important cell variation in glucocorticoid responsiveness, in a c-Src independent mechanism.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.